Product Information

PRAMIPEXOLE 0.125 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0410 per EA under NDC 64380074605. Its NADAC has been published 276 times since May 12, 2021.

FDA first approved this application on Jun 3, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAMIPEXOLE 0.125 MG TABLET

pramipexole dihydrochloride
$0.0410per EA

Strength

.125 mg/1

NDC

64380074605

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PRAMIPEXOLE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202702

FDA Approved

6/3/2014

TE Code

AB

On Market Since

2/15/2021

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for PRAMIPEXOLE 0.125 MG TABLET has been published 276 times since May 12, 2021, and over the history we have for it it has declined 18.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0410 per EA
All-time high$0.0595 (Jan 12, 2022)
All-time low$0.0350 (Nov 20, 2024)
52-week high$0.0427
52-week low$0.0404
Median price$0.0478
Average price$0.0477
Largest weekly change+23.8% (Aug 21, 2024)
Weeks tracked276
Tracking sinceMay 12, 2021

Price History

1W

-0.4%

1M

-0.4%

3M

-3.5%

6M

+0.1%

1Y

-4.0%

3Y

-15.2%

5Y

-18.2%

All

-18.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pramipexole dihydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PRAMIPEXOLE 0.125 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.125 MG TABLET, manufactured by Strides Pharma Inc., is $0.0410 per EA (NDC 64380074605), effective Aug 19, 2026.

How has the price of PRAMIPEXOLE 0.125 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has declined 18.0%. It has been tracked across 276 weekly CMS publications since May 12, 2021.

What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.125 MG TABLET?

Since May 12, 2021, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has ranged from a low of $0.0350 (Nov 20, 2024) to a high of $0.0595 (Jan 12, 2022), with a median of $0.0478 per EA.

Are there cheaper alternatives to PRAMIPEXOLE 0.125 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PRAMIPEXOLE 0.125 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PRAMIPEXOLE 0.125 MG TABLET?

PRAMIPEXOLE 0.125 MG TABLET (NDC 64380074605) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.